Portnoĭ A S, Ostroumova M N, Vacil'eva I A, Dil'man V M
Vopr Onkol. 1983;29(1):34-9.
The blood levels of hydroxycorticosteroid-11 (11-HOCS) before and after dexamethasone, somatomedins, cholesterol, triglycerides, beta-lipoproteins and cholesterol of high-density lipoproteins were studied in 55 patients with prostatic adenoma and 75 cases of prostatic cancer. It was found that the hypothalamo-pituitary system is resistant to inhibition by dexamethasone in both groups, while elevation of absolute level of 11-HOCS was observed in cases of adenoma. Patients with prostatic cancer revealed a higher blood serum-somatomedin level. Triglyceride level was relatively higher, and diabetes mellitus and hyperlipidemia (type IIb and IV) were slightly more frequent in patients with prostatic adenoma. This was matched by a relatively higher level of cholesterol and more frequent hyperlipidemia type IIa in cancer patients.
对55例前列腺腺瘤患者和75例前列腺癌患者研究了地塞米松给药前后血中11 - 羟皮质类固醇(11 - HOCS)、生长调节素、胆固醇、甘油三酯、β - 脂蛋白及高密度脂蛋白胆固醇水平。结果发现,两组下丘脑 - 垂体系统对地塞米松抑制均有抵抗,而腺瘤患者中观察到11 - HOCS绝对水平升高。前列腺癌患者血清生长调节素水平较高。甘油三酯水平相对较高,前列腺腺瘤患者中糖尿病和高脂血症(IIb型和IV型)稍多见。与此相对应,癌症患者胆固醇水平相对较高,IIa型高脂血症更常见。